Comparison of different concepts for interpretation of chromosomal aberrations in urothelial cells detected by fluorescence in situ hybridization

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

(2017) Marko Babjuk et al.   EUROPEAN UROLOGY

Biomarkers for detection and surveillance of bladder cancer

(2016) Lorne I. Budman et al.   CUAJ-Canadian Urological Association Journal

Chromosomal alterations in exfoliated urothelial cells from bladder cancer cases and healthy men: a prospective screening study

(2014) Nadine Bonberg et al.   BMC CANCER

Multicenter evaluation of the role of UroVysion FISH assay in surveillance of patients with bladder cancer: does FISH positivity anticipate recurrence?

(2014) Casey Seideman et al.   WORLD JOURNAL OF UROLOGY

Chromosomal instability and bladder cancer: the UroVysionTMtest in the UroScreen study

(2013) Nadine Bonberg et al.   BJU INTERNATIONAL

Evaluation of urovysion and cytology for bladder cancer detection

(2013) Haythem Dimashkieh et al.   CANCER CYTOPATHOLOGY

Epidemiology and Risk Factors of Urothelial Bladder Cancer

(2012) Maximilian Burger et al.   EUROPEAN UROLOGY

Influence of Urinary Tract Instrumentation and Inflammation on the Performance of Urine Markers for the Detection of Bladder Cancer

(2012) Tilman Todenhöfer et al.   UROLOGY

Exclusion of the uniform tetraploid cells significantly improves specificity of the urine fish assay

(2011) Neda A. Moatamed et al.   DIAGNOSTIC CYTOPATHOLOGY

Urine Markers for Detection and Surveillance of Non–Muscle-Invasive Bladder Cancer

(2011) Derya Tilki et al.   EUROPEAN UROLOGY

Can we still afford bladder cancer?

(2010) Arnulf Stenzl et al.   CURRENT OPINION IN UROLOGY